Expressing the sense of Congress about the Food and Drug Administration proposal to designate the use of chlorofluorocarbons in metered-dose inhalers as non-essential.

Summary

Expresses the sense of the Congress that: (1) a specified proposed Food and Drug Administration (FDA) regulation to designate the use of chlorofluorocarbons (CFCs) in metered-dose inhalers (MDIs) as nonessential so as to make MDIs using CFCs adulterated devices puts at risk the health of millions of asthma patients and does not contribute measurably to protection of the environment; and (2) the FDA should withdraw its proposal and focus its efforts on implementing existing Montreal Protocol decisions that will facilitate a transition to CFC-free MDIs by 2005.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 9 July 1997

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 9 July 1997

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 9 July 1997

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.